Patent intelligence · EP
EP 1425277
HARNSTOFF-DERIVATE ALS VANILLOID-REZEPTOR-ANTAGONISTEN FÜR DIE SCHMERZBEHANDLUNG
HARNSTOFF-DERIVATE ALS VANILLOID-REZEPTOR-ANTAGONISTEN FÜR DIE SCHMERZBEHANDLUNG
Patent details — EP 1425277
- Jurisdiction
- EP
- Status
- expired
- Grant date
- Jun 9, 2004
- Expiration
- Jun 4, 2024
- Applicant
- SMITHKLINE BEECHAM PLC [GB]
- CPC classes
- A61K 31/ 443 A I, A61K 31/ 4025 A I, A61K 31/ 4709 A I, A61K 31/ 4725 A I
Quick answer
EP 1425277 (HARNSTOFF-DERIVATE ALS VANILLOID-REZEPTOR-ANTAGONISTEN FÜR DIE SCHMERZBEHANDLUNG) is held by SMITHKLINE BEECHAM PLC [GB]. Status: expired. Granted Jun 9, 2004. Expires Jun 4, 2024 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- SMITHKLINE BEECHAM PLC [GB]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 31/ 443 A I, A61K 31/ 4025 A I, A61K 31/ 4709 A I, A61K 31/ 4725 A I, A61K31/4025, A61K31/4709
More from SMITHKLINE BEECHAM PLC [GB]
Related pharmaceutical patents in our USPTO index.
-
SA 92120308
تركيبة للاستخدام الموضعي topical composition
expired -
AT E269330
CHEMISCHE VERBINDUNGEN
expired -
SA 91110341
مستحضر موضعي لعلاج العدوى بفيروس الحلا (القوباء) Herpesvirus
expired -
HU P0302480
PYRIDINONE DERIVATIVES FOR TREATMENT OF ATHEROSCLEROSIS, PROCESS FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
expired -
AT E245157
3,9-DIAZABICYCLO-(3.3.1)-NONANYLDERIVATE, VERFAHREN UND INTERMEDIATE FÜR IHRE DARSTELLUNG UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
expired -
HK 1004528
Dentifrice compositions
expired -
HU P0204410
PYRIMIDINE-4-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE
expired
Frequently asked questions
What is US patent 1425277?
EP 1425277 (HARNSTOFF-DERIVATE ALS VANILLOID-REZEPTOR-ANTAGONISTEN FÜR DIE SCHMERZBEHANDLUNG) is held by SMITHKLINE BEECHAM PLC [GB]. Status: expired. Granted Jun 9, 2004. Expires Jun 4, 2024 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns EP 1425277?
SMITHKLINE BEECHAM PLC [GB] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does EP 1425277 expire?
Our index shows an expiration date of Jun 4, 2024 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.